Three types of recombinant human granulocyte colony-stimulating factor have equivalent biological activities in monkeys

Cytokine

Volumn 9, Issue 5, 1997, Pages 360-369

  Tanaka, Hideji ^a   Tanaka, Yoshihiro ^a   Shinagawa, Kyoko ^a   Yamagishi, Yuji ^a   Ohtaki, Kenji ^a   Asano, Katsuhiko ^a  

^a KIRIN BREWERY CO LTD   (Japan)

Author keywords

Granulocyte colony stimulating factor (G CSF); In vivo; Monkey; Pharmacodynamics; Pharmacokinetics

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONKEY; MUTATION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; MACACA FASCICULARIS;

EID: 0031149970     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0177     Document Type: Article

References (31)

1. 1. Metcalf D (1984) The Hematopoietic Colony Stimulating Factors. Amsterdam: Elsevier.
2. 2. Nicola NA, Metcalf D, Matsumoto M, Johnson GR (1983) Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells: Identification as granulocyte colony-stimulating factor (G-CSF). J Biol Chem 258:9017-9023.
3. 3. Metcalf D, Nicola NA (1983) Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells. J Cell Physiol 116:198-206.
4. 4. Welte K, Platzer E, Lu L, Gabrilove J, Levi E, Mertelsmann R, Moore MAS (1985) Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA 82:1526-1530.
5. 5. Souza LM, Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdock DC, Chazin VR, Bruszewski J, Lu H, Chen KK, Barendt J, Platzer E, Moore MAS, Mertelsmann R, Welte K (1986) Recombinant human granulocyte colony-stimulating factor; Effects on normal and leukemic myeloid cells. Science 232:61-65.
6. 6. Nagata S, Tsuchiya M, Asano S, Maziro Y, Yamazaki T, Yamamoto O, Hirata Y, Kubota N, Oheda M, Nomura H, Ono M (1986) Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319:415-418.
7. 7. Morstyn G, Campbell L, Souza LM, Alton NK, Keech J, Green M, Sheridan W, Metcalf D (1988) Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet March 26:667-672.
8. 8. Brouchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, Testa NG, Dexter TM (1987) Phase I/II study of recombinant human granulocyte-colony stimulating factor in patients receiving intensive chemotherapy for small-cell lung cancer. Br J Cancer 56:809-813.
9. 9. Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (first of two parts). N Engl J Med 327:28-35.
10. 10. Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (second of two parts). N Engl J Med 327:99-106.
11. 11. Kuga T, Komatsu Y, Yamasaki M, Sekine S, Miyaji H, Sato M, Yokoo M, Asano M, Okabe M, Morimoto M, Itoh S (1989) Mutagenesis of human granulocyte colony-stimulating factor. Biochem Biophys Res Commun 159:103-111.
12. 12. Kuwabara T, Kato Y, Okumura S, Kobayashi S, Yammoto M, Ikenaga T, Deguchi T, Hirata T (1991) Disposition of marograstim (KW-2228) (4): Pharmacokinetic studies in monkeys. Xenobio Metabol Dispos 6:887-897.
13. 13. Suzuki K, Tsunoo M, Shishido A, Kuwabara T, Kobayashi S (1991) Phase I study of KW-2228 in normal healthy volunteers. J Clin Ther Med 7:1947-1971.
14. 14. American Society of Clinical Oncology (1994) American Society of Clinical Oncology Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 12:2471-2508.
15. 15. Oheda M, Hasegawa M, Hattori K, Kuboniwa H, Kojima T, Orita T, Tomonou K, Yamazaki T, Ochi N (1990) O-linked sugar chain of human granulocyte colony-stimulating factor protects it against polymerization and denaturation allowing it to retain its biological activity. J Biol Chem 265:11432-11435.
16. 16. Kishita M, Motojima H, Oheda M, Kojima T, Kamachi S, Fukushima M, Ono M, Watari K, Asano S (1992) Stability of granulocyte colony-stimulating factor (G-CSF) in serum. Clinical Report 26:221-224.
17. 17. Nissen C, Carbonare VD, Moser Y (1994) In vitro comparison of the biological potency of glycosylated versus nonglycosylated rhG-CSF. Drug Invest 7:346-352.
18. 18. Okabe M, Asano M, Kuga T, Komatsu Y, Yamasaki M, Yokoo Y, Itoh S, Morimoto M, Oka T (1990) In vitro and in vivo hematopoietic effect of mutant human granulocyte colony-stimulating factor. Blood 75:1788-1793.
19. 19. Tamai Y (1992) Recombinant human granulocyte colony stimulating factor (rhG-CSF). Practical Hematology 2:187-192.
20. 20. Tanaka H, Tokiwa T (1990) Influence of renal and hepatic failure on the pharmacokinetics of recombinant human granulocyte colony-stimulating factor (KRN8601) in the rat. Cancer Res 50:6615-6619.
21. 21. Kato M, Amano J, Okano K, Hiramatsu Y, Kinoshita H, Okazaki A (1993) The role of the kidney on the elimination of recombinant human granulocyte colony-stimulating factor (rhG-CSF). Xenobio Metabol Dispos 8:1213-1218.
22. 22. Kuwabara T, Okumura S, Kobayashi S, Hirata T (1991) Disposition of marograstim (KW-2228) (3): pharmacokinetic studies in rats. Xenobio Metabol and Dispos 6:875-885.
23. 23. Okabe M, Asano M, Gomi K, Hirata T (1991) Effect of a mutant human granulocyte colony-stimulating factor, KW-2228 on anticancer drug-induced leukopenia in mice. Jpn Pharmacol Ther 19:2169-2179.
24. 24. Tanaka H, Kaneko T (1992) Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in mice. Blood 79:536-537.
25. 25. Tanaka H, Shinagawa K, Kuwaki T, Tsumura H, Shibuya K, Obuchi M (1993) Study on N-terminal amino acid mutated recombinant human granulocyte colony-stimulating factor. The Clinical Report 27:5135-5150.
26. 26. Azuma J, Awata S, Sawamura A, Tsuji S, Yoshida H, Seto Y, Mochizuki N, Kaneko T, Shimosaka A, Itoh H, Akahori H, Takaku F (1989) Phase I study of KRN8601 (rhG-CSF) in normal healthy volunteers: Safety and pharmacokinetics in consecutive intravenous infusion. J Clin Ther Med 5:1605-1622.
27. 27. Sekino H, Moritani K, Sugano T, Wakabayashi K, Okazaki A (1989) A phase I clinical study with recombinant human G-CSF. Med Consult New Remed 26:1660-1732.
28. 28. Kuwabara T, Kato Y, Kobayashi S, Suzuki H, Sugiyama Y (1994) Nonlinear pharmacokinetics of a recombinant human granulocyte colony-stimulating factor derivative (nartograstim): Species differences among rats, monkeys and humans. J Pharmacol Exp Ther 271:1535-1543.
29. 29. Tanaka H, Tokiwa T (1990) Pharmacokinetics of recombinant human granulocyte colony-stimulating factor studied in the rat by a sandwich enzyme-liked immunosorbent assay. J Pharmacol Exp Ther 255:724-729.
30. 30. Tanaka H, Kaneko T (1992) Development of a competitive radioimmunoassay and a sandwich enzyme-linked immunosorbent assay for recombinant human granulocyte colony-stimulating factor. Application to a pharmacokinetic study in rats. J Pharmacobio-Dyn 15:359-366.
31. 31. Gibardi M, Perrier D (1982) Pharmacokinetics, 2nd Edn Marcel Dekker, USA: New York.